B12 Injection vs Cerebrolysin
A side-by-side research comparison of B12 Injection and Cerebrolysin across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | B12 Injection | Cerebrolysin |
|---|---|---|
| Full name | Methylcobalamin (Vitamin B12) Injectable | Cerebrolysin (Brain-Derived Peptide Preparation) |
| Category | Cognitive & Nootropic | Cognitive & Nootropic |
| Status | Prescribed / OTC | Investigational |
| Mechanism | Cofactor for methionine synthase (DNA methylation) and methylmalonyl-CoA mutase (energy metabolism). Supports myelin synthesis, neurotransmitter production, and red blood cell formation. | Contains fragments mimicking NGF, BDNF, GDNF, CNTF. Enhances synaptic plasticity, promotes neuronal sprouting, reduces amyloid-beta, and stabilizes calcium homeostasis. |
| Molecular weight | 1344.38 Da | <10,000 Da (peptide fraction) |
| Half-life | ~6 days | 4-6 hours |
| Bioavailability | ~100% IM/SC | High (IM/IV) |
| Typical dose | 1000-5000 mcg | 5-30 mL |
| Frequency | 1-3x per week | Daily for 10-20 days |
| Route | Intramuscular or subcutaneous injection | Intramuscular or IV |
B12 Injection reported benefits
- Increased energy
- Improved cognitive function
- Nerve repair
- Red blood cell production
- Better sleep
- Mood enhancement
Cerebrolysin reported benefits
- Neurotrophic support
- Stroke recovery
- Memory improvement
- Neuroprotection
- Synaptic plasticity
- Approved in 40+ countries
Related comparisons
Research and educational reference only. Not medical advice.